{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:08:03Z","timestamp":1788044883030,"version":"build-2784847793"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,4,5]],"date-time":"2014-04-05T00:00:00Z","timestamp":1396656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1208\/s12248-014-9595-6","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T16:56:55Z","timestamp":1396630615000},"page":"600-608","source":"Crossref","is-referenced-by-count":27,"title":["Targeted Delivery of Curcumin to Tumors via PEG-Derivatized FTS-Based Micellar System"],"prefix":"10.1208","volume":"16","author":[{"given":"Yichao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,5]]},"reference":[{"issue":"2","key":"9595_CR1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.canlet.2004.09.041","volume":"223","author":"A Duvoix","year":"2005","unstructured":"Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E, et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 2005;223(2):181\u201390. doi: 10.1016\/j.canlet.2004.09.041 .","journal-title":"Cancer Lett"},{"issue":"3","key":"9595_CR2","first-page":"597","volume":"59","author":"T Kawamori","year":"1999","unstructured":"Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV, et al. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion\/progression stages of colon cancer. Cancer Res. 1999;59(3):597\u2013601.","journal-title":"Cancer Res"},{"issue":"20","key":"9595_CR3","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.1158\/1078-0432.CCR-05-1192","volume":"11","author":"BB Aggarwal","year":"2005","unstructured":"Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, et al. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res Off J Am Assoc Cancer Res. 2005;11(20):7490\u20138. doi: 10.1158\/1078-0432.CCR-05-1192 .","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"21","key":"9595_CR4","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.1523\/JNEUROSCI.21-21-08370.2001","volume":"21","author":"GP Lim","year":"2001","unstructured":"Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci Off J Soc Neurosci. 2001;21(21):8370\u20137.","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"11","key":"9595_CR5","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.bcp.2008.07.031","volume":"76","author":"S Reuter","year":"2008","unstructured":"Reuter S, Eifes S, Dicato M, Aggarwal BB, Diederich M. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol. 2008;76(11):1340\u201351. doi: 10.1016\/J.Bcp.2008.07.031 .","journal-title":"Biochem Pharmacol"},{"issue":"52","key":"9595_CR6","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.1038\/sj.onc.1204997","volume":"20","author":"A Mukhopadhyay","year":"2001","unstructured":"Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P, Aggarwal BB. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene. 2001;20(52):7597\u2013609. doi: 10.1038\/Sj.Onc.1204997 .","journal-title":"Oncogene"},{"issue":"2","key":"9595_CR7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.canlet.2008.03.009","volume":"269","author":"AB Kunnumakkara","year":"2008","unstructured":"Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008;269(2):199\u2013225. doi: 10.1016\/J.Canlet.2008.03.009 .","journal-title":"Cancer Lett"},{"issue":"2","key":"9595_CR8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/sj.onc.1201941","volume":"17","author":"YR Chen","year":"1998","unstructured":"Chen YR, Tan TH. Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene. 1998;17(2):173\u20138. doi: 10.1038\/Sj.Onc.1201941 .","journal-title":"Oncogene"},{"issue":"42","key":"9595_CR9","doi-asserted-by":"crossref","first-page":"24995","DOI":"10.1074\/jbc.270.42.24995","volume":"270","author":"S Singh","year":"1995","unstructured":"Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem. 1995;270(42):24995\u20135000.","journal-title":"J Biol Chem"},{"issue":"1","key":"9595_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcb.10495","volume":"89","author":"LR Chaudhary","year":"2003","unstructured":"Chaudhary LR, Hruska KA. Inhibition of cell survival signal protein kinase B\/Akt by curcumin in human prostate cancer cells. J Cell Biochem. 2003;89(1):1\u20135. doi: 10.1002\/jcb.10495 .","journal-title":"J Cell Biochem"},{"issue":"18","key":"9595_CR11","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.1158\/1078-0432.CCR-05-0171","volume":"11","author":"S Lev-Ari","year":"2005","unstructured":"Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, et al. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin Cancer Res Off J Am Assoc Cancer Res. 2005;11(18):6738\u201344. doi: 10.1158\/1078-0432.CCR-05-0171 .","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"6","key":"9595_CR12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/07357900701359577","volume":"25","author":"S Lev-Ari","year":"2007","unstructured":"Lev-Ari S, Vexler A, Starr A, Ashkenazy-Voghera M, Greif J, Aderka D, et al. Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines. Cancer Investig. 2007;25(6):411\u20138. doi: 10.1080\/07357900701359577 .","journal-title":"Cancer Investig"},{"issue":"1","key":"9595_CR13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.canlet.2004.10.051","volume":"224","author":"M Notarbartolo","year":"2005","unstructured":"Notarbartolo M, Poma P, Perri D, Dusonchet L, Cervello M, D\u2019Alessandro N. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Cancer Lett. 2005;224(1):53\u201365. doi: 10.1016\/j.canlet.2004.10.051 .","journal-title":"Cancer Lett"},{"key":"9595_CR14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0076-6879(07)00432-6","volume":"439","author":"B Rotblat","year":"2008","unstructured":"Rotblat B, Ehrlich M, Haklai R, Kloog Y. The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the spatiotemporal localization of active Ras: a potential treatment for cancer. Method Enzymol. 2008;439:467\u201389. doi: 10.1016\/S0076-6879(07)00432-6 .","journal-title":"Method Enzymol"},{"issue":"38","key":"9595_CR15","doi-asserted-by":"crossref","first-page":"22263","DOI":"10.1074\/jbc.270.38.22263","volume":"270","author":"M Marom","year":"1995","unstructured":"Marom M, Haklai R, Benbaruch G, Marciano D, Egozi Y, Kloog Y. Selective-inhibition of Ras-dependent cell-growth by farnesylthiosalicylic acid. J Biol Chem. 1995;270(38):22263\u201370.","journal-title":"J Biol Chem"},{"issue":"10","key":"9595_CR16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1357-4310(00)01789-5","volume":"6","author":"Y Kloog","year":"2000","unstructured":"Kloog Y, Cox AD. RAS inhibitors: potential for cancer therapeutics. Mol Med Today. 2000;6(10):398\u2013402.","journal-title":"Mol Med Today"},{"issue":"6","key":"9595_CR17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.drup.2005.11.002","volume":"8","author":"R Blum","year":"2005","unstructured":"Blum R, Kloog Y. Tailoring Ras-pathway\u2014inhibitor combinations for cancer therapy. Drug Resist Updat Rev Commentaries Antimicrob Anticancer Chemother. 2005;8(6):369\u201380. doi: 10.1016\/j.drup.2005.11.002 .","journal-title":"Drug Resist Updat Rev Commentaries Antimicrob Anticancer Chemother"},{"issue":"3","key":"9595_CR18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ccr.2013.08.004","volume":"24","author":"SK McLaughlin","year":"2013","unstructured":"McLaughlin SK, Olsen SN, Dake B, De Raedt T, Lim E, Bronson RT, et al. The RasGAP gene, RASAL2, is a tumor and metastasis suppressor. Cancer Cell. 2013;24(3):365\u201378. doi: 10.1016\/j.ccr.2013.08.004 .","journal-title":"Cancer Cell"},{"issue":"3","key":"9595_CR19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nm.2100","volume":"16","author":"J Min","year":"2010","unstructured":"Min J, Zaslavsky A, Fedele G, McLaughlin SK, Reczek EE, De Raedt T, et al. An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB. Nat Med. 2010;16(3):286\u201394. doi: 10.1038\/nm.2100 .","journal-title":"Nat Med"},{"issue":"2","key":"9595_CR20","first-page":"555","volume":"8","author":"M Gana-Weisz","year":"2002","unstructured":"Gana-Weisz M, Halaschek-Wiener J, Jansen B, Elad G, Haklai R, Kloog Y. The Ras inhibitor S-trans, trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance. Clin Cancer Res. 2002;8(2):555\u201365.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"9595_CR21","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1517\/13543784.8.12.2121","volume":"8","author":"Y Kloog","year":"1999","unstructured":"Kloog Y, Cox AD, Sinensky M. Concepts in Ras-directed therapy. Expert Opin Investig Drugs. 1999;8(12):2121\u201340. doi: 10.1517\/13543784.8.12.2121 .","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"9595_CR22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00280-007-0451-6","volume":"61","author":"R Haklai","year":"2008","unstructured":"Haklai R, Elad-Sfadia G, Egozi Y, Kloog Y. Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice. Cancer Chemother Pharmacol. 2008;61(1):89\u201396. doi: 10.1007\/s00280-007-0451-6 .","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"9595_CR23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.25367","volume":"128","author":"A Biran","year":"2011","unstructured":"Biran A, Brownstein M, Haklai R, Kloog Y. Downregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: a new drug combination for cancer therapy. Int J Cancer J Int Cancer. 2011;128(3):691\u2013701. doi: 10.1002\/ijc.25367 .","journal-title":"Int J Cancer J Int Cancer"},{"issue":"12","key":"9595_CR24","doi-asserted-by":"crossref","first-page":"e51449","DOI":"10.1371\/journal.pone.0051449","volume":"7","author":"L Mologni","year":"2012","unstructured":"Mologni L, Brussolo S, Ceccon M, Gambacorti-Passerini C. Synergistic effects of combined Wnt\/KRAS inhibition in colorectal cancer cells. PLoS ONE. 2012;7(12):e51449. doi: 10.1371\/journal.pone.0051449 .","journal-title":"PLoS ONE"},{"issue":"6","key":"9595_CR25","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807\u201318. doi: 10.1021\/mp700113r .","journal-title":"Mol Pharm"},{"issue":"1","key":"9595_CR26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jps.22238","volume":"100","author":"A Kraitzer","year":"2011","unstructured":"Kraitzer A, Kloog Y, Haklai R, Zilberman M. Composite fiber structures with antiproliferative agents exhibit advantageous drug delivery and cell growth inhibition in vitro. J Pharm Sci. 2011;100(1):133\u201349. doi: 10.1002\/jps.22238 .","journal-title":"J Pharm Sci"},{"issue":"3","key":"9595_CR27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1021\/bc300608h","volume":"24","author":"XL Zhang","year":"2013","unstructured":"Zhang XL, Lu JQ, Huang YX, Zhao WC, Chen YC, Li J, et al. PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel. Bioconjug Chem. 2013;24(3):464\u201372. doi: 10.1021\/Bc300608h .","journal-title":"Bioconjug Chem"},{"issue":"7","key":"9595_CR28","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1021\/bc3000468","volume":"23","author":"YX Huang","year":"2012","unstructured":"Huang YX, Lu JQ, Gao X, Li J, Zhao WC, Sun M, et al. PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxel. Bioconjug Chem. 2012;23(7):1443\u201351. doi: 10.1021\/Bc3000468 .","journal-title":"Bioconjug Chem"},{"issue":"3","key":"9595_CR29","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1021\/bi952436a","volume":"35","author":"X Gao","year":"1996","unstructured":"Gao X, Huang L. Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry. 1996;35(3):1027\u201336. doi: 10.1021\/bi952436a .","journal-title":"Biochemistry"},{"issue":"1","key":"9595_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(02)00192-1","volume":"184","author":"C Ramachandran","year":"2002","unstructured":"Ramachandran C, Fonseca HB, Jhabvala P, Escalon EA, Melnick SJ. Curcumin inhibits telomerase activity through human telomerase reverse transcriptase in MCF-7 breast cancer cell line. Cancer Lett. 2002;184(1):1\u20136.","journal-title":"Cancer Lett"},{"issue":"4","key":"9595_CR31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/pros.10336","volume":"58","author":"RA McPherson","year":"2004","unstructured":"McPherson RA, Conaway MC, Gregory CW, Yue W, Santen RJ. The novel ras antagonist, farnesylthiosalicylate, suppresses growth of prostate cancer in vitro. Prostate. 2004;58(4):325\u201334. doi: 10.1002\/Pros.10336 .","journal-title":"Prostate"},{"issue":"10","key":"9595_CR32","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/mc.20849","volume":"51","author":"P Starkel","year":"2012","unstructured":"Starkel P, Charette N, Borbath I, Schneider-Merck T, De Saeger C, Abarca J, et al. Ras inhibition in hepatocarcinoma by S-trans-trans-farnesylthiosalicylic acid: association of its tumor preventive effect with cell proliferation, cell cycle events, and angiogenesis. Mol Carcinog. 2012;51(10):816\u201325. doi: 10.1002\/mc.20849 .","journal-title":"Mol Carcinog"},{"issue":"1","key":"9595_CR33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0360-3016(79)90044-0","volume":"5","author":"GG Steel","year":"1979","unstructured":"Steel GG, Peckham MJ. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys. 1979;5(1):85\u201391.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"9595_CR34","first-page":"3051","volume":"118","author":"CW Kinkade","year":"2008","unstructured":"Kinkade CW, Castillo-Martin M, Puzio-Kuter A, Yan J, Foster TH, Gao H, et al. Targeting AKT\/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model. J Clin Invest. 2008;118(9):3051\u201364. doi: 10.1172\/Jci34764 .","journal-title":"J Clin Invest"},{"issue":"4","key":"9595_CR35","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ijc.10213","volume":"98","author":"KS Smalley","year":"2002","unstructured":"Smalley KS, Eisen TG. Farnesyl thiosalicylic acid inhibits the growth of melanoma cells through a combination of cytostatic and pro-apoptotic effects. Int J Cancer J Int Cancer. 2002;98(4):514\u201322.","journal-title":"Int J Cancer J Int Cancer"},{"issue":"1","key":"9595_CR36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1124\/mol.106.033167","volume":"72","author":"H Aoki","year":"2007","unstructured":"Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB, Kondo Y. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol. 2007;72(1):29\u201339. doi: 10.1124\/mol.106.033167 .","journal-title":"Mol Pharmacol"},{"issue":"6","key":"9595_CR37","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/cncr.21300","volume":"104","author":"L Li","year":"2005","unstructured":"Li L, Braiteh FS, Kurzrock R. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer. 2005;104(6):1322\u201331. doi: 10.1002\/cncr.21300 .","journal-title":"Cancer"},{"issue":"1\u20132","key":"9595_CR38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drudis.2011.09.009","volume":"17","author":"MM Yallapu","year":"2012","unstructured":"Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today. 2012;17(1\u20132):71\u201380. doi: 10.1016\/j.drudis.2011.09.009 .","journal-title":"Drug Discov Today"},{"issue":"3","key":"9595_CR39","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.nano.2011.06.011","volume":"8","author":"YL Lin","year":"2012","unstructured":"Lin YL, Liu YK, Tsai NM, Hsieh JH, Chen CH, Lin CM, et al. A Lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells. Nanomed Nanotechnol. 2012;8(3):318\u201327. doi: 10.1016\/J.Nano.2011.06.011 .","journal-title":"Nanomed Nanotechnol"},{"issue":"1\u20132","key":"9595_CR40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijpharm.2012.12.032","volume":"443","author":"L Liu","year":"2013","unstructured":"Liu L, Sun L, Wu QJ, Guo WH, Li L, Chen YS, et al. Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis. Int J Pharm. 2013;443(1\u20132):175\u201382. doi: 10.1016\/J.Ijpharm.2012.12.032 .","journal-title":"Int J Pharm"},{"issue":"4","key":"9595_CR41","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.biomaterials.2012.10.068","volume":"34","author":"CY Gong","year":"2013","unstructured":"Gong CY, Deng SY, Wu QJ, Xiang ML, Wei XW, Li L, et al. Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles. Biomaterials. 2013;34(4):1413\u201332. doi: 10.1016\/J.Biomaterials.2012.10.068 .","journal-title":"Biomaterials"},{"issue":"4","key":"9595_CR42","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1039\/c0nr00758g","volume":"3","author":"M Gou","year":"2011","unstructured":"Gou M, Men K, Shi H, Xiang M, Zhang J, Song J, et al. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale. 2011;3(4):1558\u201367. doi: 10.1039\/c0nr00758g .","journal-title":"Nanoscale"},{"issue":"2","key":"9595_CR43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/jbm.a.31584","volume":"86","author":"Z Ma","year":"2008","unstructured":"Ma Z, Haddadi A, Molavi O, Lavasanifar A, Lai R, Samuel J. Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J Biomed Mater Res A. 2008;86(2):300\u201310. doi: 10.1002\/jbm.a.31584 .","journal-title":"J Biomed Mater Res A"},{"issue":"9","key":"9595_CR44","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/mp2006455","volume":"9","author":"S Podaralla","year":"2012","unstructured":"Podaralla S, Averineni R, Alqahtani M, Perumal O. Synthesis of novel biodegradable methoxy poly(ethylene glycol)-zein micelles for effective delivery of curcumin. Mol Pharm. 2012;9(9):2778\u201386. doi: 10.1021\/mp2006455 .","journal-title":"Mol Pharm"},{"issue":"10","key":"9595_CR45","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1021\/bm800683f","volume":"9","author":"A Sahu","year":"2008","unstructured":"Sahu A, Kasoju N, Bora U. Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells. Biomacromolecules. 2008;9(10):2905\u201312. doi: 10.1021\/bm800683f .","journal-title":"Biomacromolecules"},{"issue":"12","key":"9595_CR46","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1007\/s11095-012-0848-8","volume":"29","author":"R Yang","year":"2012","unstructured":"Yang R, Zhang S, Kong D, Gao X, Zhao Y, Wang Z. Biodegradable polymer-curcumin conjugate micelles enhance the loading and delivery of low-potency curcumin. Pharm Res. 2012;29(12):3512\u201325. doi: 10.1007\/s11095-012-0848-8 .","journal-title":"Pharm Res"},{"issue":"1","key":"9595_CR47","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcis.2010.10.024","volume":"354","author":"Z Song","year":"2011","unstructured":"Song Z, Feng R, Sun M, Guo C, Gao Y, Li L, et al. Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: preparation, pharmacokinetics and distribution in vivo. J Colloid Interface Sci. 2011;354(1):116\u201323. doi: 10.1016\/j.jcis.2010.10.024 .","journal-title":"J Colloid Interface Sci"},{"key":"9595_CR48","first-page":"4487","volume":"7","author":"K Wang","year":"2012","unstructured":"Wang K, Zhang T, Liu L, Wang X, Wu P, Chen Z, et al. Novel micelle formulation of curcumin for enhancing antitumor activity and inhibiting colorectal cancer stem cells. Int J Nanomedicine. 2012;7:4487\u201397. doi: 10.2147\/IJN.S34702 .","journal-title":"Int J Nanomedicine"},{"issue":"1\u20133","key":"9595_CR49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.colsurfa.2011.08.031","volume":"390","author":"L Song","year":"2011","unstructured":"Song L, Shen YY, Hou JW, Lei L, Guo SR, Qian CY. Polymeric micelles for parenteral delivery of curcumin: preparation, characterization and in vitro evaluation. Colloid Surf A. 2011;390(1\u20133):25\u201332. doi: 10.1016\/J.Colsurfa.2011.08.031 .","journal-title":"Colloid Surf A"},{"issue":"12","key":"9595_CR50","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/S0731-7085(96)02024-9","volume":"15","author":"YJ Wang","year":"1997","unstructured":"Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, et al. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal. 1997;15(12):1867\u201376.","journal-title":"J Pharm Biomed Anal"},{"issue":"4","key":"9595_CR51","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0090-9556(24)15211-7","volume":"27","author":"MH Pan","year":"1999","unstructured":"Pan MH, Huang TM, Lin JK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos Biol Fate Chem. 1999;27(4):486\u201394.","journal-title":"Drug Metab Dispos Biol Fate Chem"},{"issue":"25","key":"9595_CR52","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1016\/j.biomaterials.2010.04.062","volume":"31","author":"C Mohanty","year":"2010","unstructured":"Mohanty C, Sahoo SK. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials. 2010;31(25):6597\u2013611. doi: 10.1016\/j.biomaterials.2010.04.062 .","journal-title":"Biomaterials"},{"issue":"1\u20132","key":"9595_CR53","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","volume":"65","author":"H Maeda","year":"2000","unstructured":"Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65(1\u20132):271\u201384. doi: 10.1016\/S0168-3659(99)00248-5 .","journal-title":"J Control Release"},{"issue":"12","key":"9595_CR54","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nnano.2011.166","volume":"6","author":"H Cabral","year":"2011","unstructured":"Cabral H, Matsumoto Y, Mizuno K, Chen Q, Murakami M, Kimura M, et al. Accumulation of sub-100\u00a0nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol. 2011;6(12):815\u201323. doi: 10.1038\/Nnano.2011.166 .","journal-title":"Nat Nanotechnol"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-014-9595-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-014-9595-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-014-9595-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:48:23Z","timestamp":1746172103000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-014-9595-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,5]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["9595"],"URL":"https:\/\/doi.org\/10.1208\/s12248-014-9595-6","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,5]]}}}